当前位置:首页 - 行情中心 - 戴维医疗(300314) - 财务分析 - 利润表

戴维医疗

(300314)

  

流通市值:18.50亿  总市值:37.07亿
流通股本:1.44亿   总股本:2.88亿

利润表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、营业总收入121,163,868.56527,026,028.11402,925,721.56265,824,458.42
营业收入121,163,868.56527,026,028.11402,925,721.56265,824,458.42
二、营业总成本100,821,497453,517,695.61335,740,052.47215,490,046.49
营业成本51,945,737.99229,413,073.35174,144,094.74111,091,872.38
税金及附加858,533.26,886,454.853,844,503.013,190,684.43
销售费用20,993,021.4107,551,186.7878,471,072.9352,683,236.4
管理费用14,751,351.1764,892,027.2645,909,038.3729,536,942.22
研发费用13,897,552.955,459,129.0138,881,143.7825,011,237.72
财务费用-1,624,699.66-10,684,175.64-5,509,800.36-6,023,926.66
其中:利息费用440,230.27472,108.92365,287.52254,170.94
其中:利息收入1,908,155.2210,713,701.667,504,563.445,754,090.81
加:公允价值变动收益-435,315.07--
加:投资收益2,910,678.58-10,073,085.92-873,836.79-3,132,061.27
资产处置收益-35,029.41-7,567.964,578.89-27,356.62
资产减值损失(新)--5,006,911.77--
信用减值损失(新)-849,851.23-298,130.3-1,917,759.3-1,033,274.02
其他收益3,472,227.9310,236,111.167,517,469.386,757,919.06
营业利润平衡项目0000
四、营业利润25,840,397.4368,794,062.7871,916,121.2752,899,639.08
加:营业外收入25,710.37817,090.27196,909.7378,133.43
减:营业外支出370.086,228,998.62226,921.15180,050.76
利润总额平衡项目0000
五、利润总额25,865,737.7263,382,154.4371,886,109.8552,797,721.75
减:所得税费用3,298,068.686,118,840.38,578,237.796,271,576.39
六、净利润22,567,669.0457,263,314.1363,307,872.0646,526,145.36
持续经营净利润22,567,669.0457,263,314.1363,307,872.0646,526,145.36
归属于母公司股东的净利润22,567,669.0457,263,314.1363,307,872.0646,526,145.36
(一)基本每股收益0.080.20.220.16
(二)稀释每股收益0.080.20.220.16
八、其他综合收益416,486.79-578,357.06306,790.36-171,801.45
归属于母公司股东的其他综合收益416,486.79-578,357.06306,790.36-171,801.45
九、综合收益总额22,984,155.8356,684,957.0763,614,662.4246,354,343.91
归属于母公司股东的综合收益总额22,984,155.8356,684,957.0763,614,662.4246,354,343.91
公告日期2025-04-282025-04-092024-10-232024-08-20
审计意见(境内)标准无保留意见
TOP↑